Clinical Endpoints and Biomarkers
Functional measures and imaging biomarkers are increasingly important because visual acuity alone may miss meaningful changes in mobility, retinal function, and disease progression. Clinical endpoints in IRD trials are expanding beyond sta…
1 sources - 3 claims
Functional measures and imaging biomarkers are increasingly important because visual acuity alone may miss meaningful changes in mobility, retinal function, and disease progression. Clinical endpoints in IRD trials are expanding beyond standard visual acuity to include functional and imaging measures. Deep-learning-based imaging and precise genotyping may enable objective, high-throughput endpoint quantification and improve trial stratification.